Clinical Trials Logo
  1. Home
  2. Cluster Headache
  3. NCT02895256
  4. Details
NCT02895256 Clinical Trial

Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study

Cluster Headache Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02895256
Other study ID # 2016-04-155
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 2016
Est. completion date April 2021

Study information
Verified date March 2020
Source Samsung Medical Center
Contact Mi Ji Lee, MD
Phone 82-2-3410-1895
Email mirony.lee@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cluster headache is a syndrome characterized by disabling headache and accompanying autonomic symptoms. Despite cluster headache is called "suicide headache", its natural history has not been well investigated. The investigators aimed to investigate its disease course, overall prognosis, and treatment pattern in retrospective cohort.

Recruitment information / eligibility
Status Recruiting
Enrollment 70
Est. completion date April 2021
Est. primary completion date April 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients who were diagnosed as cluster headache

- More than 5 years after the first visit

Exclusion Criteria:

- Subjects who refused the telephone visit

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Any treatment for cluster headache

Locations
Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)
Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary overall prognosis active disease: at least one bout within the past 5 years Remission: no headache for 5 years and twice of the usual remission period at least 5 years after the first visit
Primary Changes in the length of active/inactive periods at least 5 years after the first visit
Primary Changes in seasonal and diurnal predilections at least 5 years after the first visit
Primary Changes in autonomic symptoms at least 5 years after the first visit
Primary Changes in treatment responses at least 5 years after the first visit
Secondary Any depression at least 5 years after the first visit
Secondary Any suicidal thoughts (active/passive), plans, and attempts ictal vs interictal at least 5 years after the first vis
See also
  Status Clinical Trial Phase
Recruiting NCT05264714 - Cluster Headache Treatment With Rimegepant Phase 2
Completed NCT01677026 - Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
Terminated NCT00203190 - A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache Phase 4
Terminated NCT04570475 - High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache Phase 3
Completed NCT04066023 - Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches Phase 2/Phase 3
Withdrawn NCT04353505 - Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache Phase 1
Completed NCT02019017 - Botox Injection in Treatment of Cluster Headache Phase 1/Phase 2
Completed NCT05153876 - An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Recruiting NCT05324748 - Repeated GON Injections in CCH Phase 3
Completed NCT02782533 - DBS of the Third Ventricle for Cluster Headache and Obesity N/A
Completed NCT04179266 - Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache Phase 1/Phase 2
Recruiting NCT04406259 - Atrioventricular Block and Cluster Headache (SEVA) Phase 4
Recruiting NCT06206772 - Resting State Functional Connectivity in Cluster Headache
Recruiting NCT03944876 - Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache Phase 3
Not yet recruiting NCT05857098 - Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients
Recruiting NCT02910323 - The Will Erwin Headache Research Center - Cluster Headache Study
Terminated NCT00458770 - Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks N/A
Completed NCT00662935 - Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH) N/A
Active, not recruiting NCT03511846 - Pain Biomarker Study Phase 1
Completed NCT00184587 - Prophylactic Treatment of Episodic Cluster Headache Phase 2